Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic rat

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 7, 2013, Pages 1082-1090

  Sarkar, Sraboni ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Adh; Blood EtOH Concentration; Cyp2e1; HIV 1

Indexed keywords

ALCOHOL; CYTOCHROME P450 2E1; DOPAMINE RECEPTOR; METABOTROPIC RECEPTOR;

ALCOHOL BLOOD LEVEL; ALCOHOL METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; BLOOD; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE; GENE EXPRESSION; IMMUNE RESPONSE; LEARNING; LIVER; MALE; MEMORY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SPLEEN;

ADH; BLOOD ETOH CONCENTRATION; CYP2E1; HIV-1;

ANIMALS; BINGE DRINKING; ETHANOL; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; MALE; RATS; RATS, INBRED F344; RATS, TRANSGENIC; TIME FACTORS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

EID: 84879889958     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12077     Document Type: Article

References (39)

1. Acheampong E, Mukhtar M, Parveen Z, Ngoubilly N, Ahmad N, Patel C, Pomerantz RJ (2002) Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304:222-234.
2. Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A (2010) Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 26:511-518.
3. CDC (2010b) Fact Sheets: Binge Drinking, Vol. 2011. Center for Disease Control and Prevention, Atlanta, GA.
4. Chander G (2011) Addressing alcohol use in HIV-infected persons. Top Antivir Med 19:143-147.
5. Chang SL, Beltran JA, Swarup S (2007a) Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 81:8406-8411.
6. Chang SL, Ocasio F, Beltran JA (2007b) Immunodeficient parameters in the HIV-1 transgenic rat model. Am J Infect Dis 3:202-207.
7. Chang SL, Patel NA, Romero AA (1995) Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res 679:89-98.
8. Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin Exp Res 22:1927-1942.
9. Courtney KE, Polich J (2009) Binge drinking in young adults: data, definitions, and determinants. Psychol Bull 135:142-156.
10. Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 30:5-13.
11. Falk S, Stutte HJ (1990) The spleen in HIV infection-morphological evidence of HIV-associated macrophage dysfunction. Res Virol 141:161-169.
12. Flora G, Pu H, Lee YW, Ravikumar R, Nath A, Hennig B, Toborek M (2005) Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue. Exp Neurol 191:2-12.
13. Guihot A, Bourgarit A, Carcelain G, Autran B (2011) Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol 32:131-137.
14. Haorah J, Heilman D, Diekmann C, Osna N, Donohue TM Jr, Ghorpade A, Persidsky Y (2004) Alcohol and HIV decrease proteasome and immunoproteasome function in macrophages: implications for impaired immune function during disease. Cell Immunol 229:139-148.
15. Klatt EC, Meyer PR (1987) Pathology of the spleen in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 111:1050-1053.
16. Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15:14-24.
17. Lawson MA, Kelley KW, Dantzer R (2011) Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2, 3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav Immun 25:1569-1575.
18. Liu X, Mao X, Chang SL (2011) Altered gene expression in the spleen of adolescent rats following high ethanol concentration binge drinking. Int J Clin Exp Med 4:252-257.
19. Lucas GM, Gebo KA, Chaisson RE, Moore RD (2002) Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16:767-774.
20. Mayne M, Holden CP, Nath A, Geiger JD (2000) Release of calcium from inositol 1, 4, 5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol 164:6538-6542.
21. Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5:606-616.
22. Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS (2003) Binge drinking among US adults. JAMA 289:70-75.
23. Neri E, Musante V, Pittaluga A (2007) Effects of the HIV-1 viral protein TAT on central neurotransmission: role of group I metabotropic glutamate receptors. Int Rev Neurobiol 82:339-356.
24. NIAAA (2012) Moderate & Binge Drinking. NIAAA, Rockville, MD.
25. Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218:94-101.
26. Pohorecky LA (1977) Biphasic action of ethanol. Biobehav Rev 1:231-240.
27. Prakash O, Zhang P, Xie M, Ali M, Zhou P, Coleman R, Stoltz DA, Bagby GJ, Shellito JE, Nelson S (1998) The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice. Alcohol Clin Exp Res 22:2043-2049.
28. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98:9271-9276.
29. Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, Levenson SM, Hingson R (1998) Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 158:734-740.
30. Sarkar S, Mao X, Liu C, Chang SL (2013) Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res 37(Suppl 1):E70-E78.
31. Scheller C, Arendt G, Nolting T, Antke C, Sopper S, Maschke M, Obermann M, Angerer A, Husstedt IW, Meisner F, Neuen-Jacob E, Muller HW, Carey P, Ter Meulen V, Riederer P, Koutsilieri E (2010) Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses. J Neural Transm 117:699-705.
32. Siegel M, Dejong W, Naimi TS, Heeren T, Rosenbloom DL, Ross C, Ostroff J, Jernigan DH (2011) Alcohol brand preferences of underage youth: results from a pilot survey among a national sample. Subst Abus 32:191-201.
33. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W (2000) Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67:553-558.
34. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612-616.
35. Valenzuela CF (1997) Alcohol and neurotransmitter interactions. Alcohol Health Res World 21:144-148.
36. Vigorito M, LaShomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2:319-328.
37. Volberding PA, Deeks SG (2010) Antiretroviral therapy and management of HIV infection. Lancet 376:49-62.
38. Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M (2001) Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 54(Suppl 1):S91-S98.
39. Zakhari S (2006) Overview: how is alcohol metabolized by the body? Alcohol Res Health 29:245-254.